Cargando…
Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
Based on data analysis of 9649 Chinese primary NSCLC patients, we calculated the exact proportion of EGFR subtypes in NSCLC and evaluated the TMB level, PD-L1 expression level and tumor immune microenvironment among different EGFR mutation subtypes. Postoperative follow-up data for 98 patients were...
Autores principales: | Lei, Youming, Wang, Kun, Liu, Yinqiang, Wang, Xuming, Xiang, Xudong, Ning, Xiangu, Ding, Wanbao, Duan, Jin, Li, Dingbiao, Zhao, Wei, Li, Yi, Zhang, Fujun, Luo, Xiaoyu, Shi, Yunfei, Wang, Ying, Huang, Depei, Bai, Yuezong, Zhang, Hushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899028/ https://www.ncbi.nlm.nih.gov/pubmed/35265073 http://dx.doi.org/10.3389/fimmu.2022.811601 |
Ejemplares similares
-
The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review
por: Ning, Xiangu, et al.
Publicado: (2021) -
Case Report: Response to Almonertinib in a Patient With Metastatic NSCLC Resistant to Osimertinib due to Acquired EGFR L718Q Mutation
por: Shen, Gang, et al.
Publicado: (2021) -
Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
por: Liu, Yinqiang, et al.
Publicado: (2023) -
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
por: Zhao, Xiaolong, et al.
Publicado: (2021) -
A Computed Tomography-Derived Radiomics Approach for Predicting Uncommon EGFR Mutation in Patients With NSCLC
por: Chen, Wufei, et al.
Publicado: (2021)